Anaesthetic management of a patient with anti-NMDA receptor encephalitis INTRODUCTION Anti-N-methyl-D-aspartate (NMDA) receptor (NMDA-R) encephalitis is a recently described neurological disorder, an immune-mediated encephalitis caused by production of antibodies to the NMDA-R, now a recognised cause of psychosis, movement disorders and autonomic dysfunction. [1, 2] Though it is the second most frequent cause of immune-mediated encephalitis, it is usually under-diagnosed. Many anaesthetic medications interact with NMDA-Rs with risks during induction and maintenance of anaesthesia. [3] We report a patient with documented anti-NMDA-R encephalitis who was scheduled for surgery for right salpingo-oophorectomy under general anaesthesia.
CASE REPORT
A 32-year-old female (154 cm, 73 kg) with no remarkable medical history was admitted to the hospital with complaints of insomnia, headache and irrelevant talk followed by three episodes of generalised tonic General anaesthesia was induced with fentanyl (1 mg/kg), midazolam (0.05 mg/kg) and propofol (2mg/ kg) and atracurium (0.5 mg/kg) and was maintained with fentanyl (0.3 mg/kg) IV, oxygen (1L/min) and compressed air (1.5 L/min), isoflurane (0.5%) through the tracheostomy. Patient was monitored with electrocardiography, non-invasive blood pressure, capnography, pulse oximetry and bispectral index. Surgery was completed without any complications. Patient was sent to the intensive care unit on mechanical ventilation. Subsequent follow-up after a week showed improvement in her neurological status; she was more alert with decreased convulsions, obeyed simple verbal commands. Tracheostomy was decannulated, but her psychiatric symptoms persisted with irrelevant talking and restlessness and agitation intermittently. EEG suggested improved activity. Repeat anti-NMDA-R antibodies titre was positive but reduced. She was subsequently mobilised and discharged with instructions for regular follow-up. At 3 months follow-up, she was alert, oriented, and had occasional episodes of agitation.
DISCUSSION
N-methyl-D-aspartate receptor, α-amino-5-methyl-3-hydroxy-4-isoxazole propionic acid receptor and kainate receptor are the three subtypes of ionotropic glutamate receptors. Ectopic brain tissue found in teratoma leads to the formation of anti NMDA-R antibodies and induces glutamatergic transmission impairment. NMDA-Rs are excitatory, tetrameric receptors. In NMDA-R encephalitis, NMDA-R antibodies decrease NMDA-R surface density and synaptic localisation via selective antibody-mediated capping and internalisation of surface NMDA-Rs that correlates with antibody titres. [4, 5] Originally described by Dalmau et al., in 2007 in women of age 19-24 years, it is associated with ovarian teratomas in 54% cases. [1] It has a characteristic presentation with psychiatric symptoms, behavioural or personality disturbances, central hypoventilation, paroxysmal sympathetic hyperactivity, seizures and then progresses to an unresponsive state during which periods of catatonia and agitation alternate. [1, 2] Immunotherapy is based on steroids, and subsequently on IV immunoglobulin or plasma exchange. Early removal of an underlying tumour may be associated with a good prognosis; most of the patients fully recover or have mild sequelae after removal and immunotherapy. The improvement is over several months. Coma, psychosis and dyskinesia improve first, then social behaviour and executive function. [1] The anaesthetic considerations are related to autonomic instability, including hyperthermia, tachycardia, hypertension and bradycardia. Various anaesthetic drugs like ketamine, propofol, opioids and inhaled agents like nitrous oxide, sevoflurane acting on NMDA-R, may behave unpredictably. Ketamine binds to phencyclidine site of ion channel of NMDA-R, acting as an antagonist to inhibit the influx of Na + and Ca 2+ , causing similar clinical features as the disease itself. Propofol inhibits the NMDA subtype of glutamate receptor. Depression of NMDA-mediated excitatory neurotransmission may contribute to the anaesthetic, amnesic and anti-convulsant properties of propofol. [6] Inhalational gases like nitrous oxide reduces the excitatory currents induced by NMDA-R in the basolateral amygdala. This is associated with anaesthesia-induced amnesia of nitrous oxide. [7, 8] Xenon has been shown to inhibit the NMDA-activated currents in hippocampal neurons. [9] Sevoflurane inhibits NMDA-gated currents and NMDA-induced mitochondria membrane depolarisation, could possibly worsen the clinical presentation of these
INTRODUCTION
A myriad of haematological manifestations are reported with tuberculosis (TB) such as anaemia, leucocytosis and pancytopenia. Thrombocytopenia occurring in association with TB can be immune mediated, often induced by anti-tubercular drugs. Immune-mediated thrombocytopenia due to TB itself is extremely rare. Isolated thrombocytopenia has been reported in 23-43% of patients with disseminated TB. [1] Newly diagnosed immune thrombocytopenia in TB is rare; only 27 cases have been reported so far. [2] When a patient with TB presents with haemoptysis to the Intensive Care Unit (ICU), one should rule out coexisting thrombocytopenia. Untreated thrombocytopenia may result in dreaded complications such as retro-orbital, retro-peritoneal and intracranial haemorrhage.
CASE REPORT
A 30-year-old male presented with epistaxis and haemoptysis to the casualty. He was diagnosed with sputum positive pulmonary TB 1-week before and was on category one intermittent anti-tubercular treatment (ATT) regimen. On examination, his pulse rate was 90/min; blood pressure was 116/78 mm Hg, and respiratory rate was 22 breaths/min. Trachea was central, dull note was heard in right infra-clavicular, mammary, infra-axillary and inter-scapular areas along with bronchial breath sounds. Other systemic examinations were within normal limits.
